Novelix Pharma: Promoter Group Acquires 7.75 Lakh Shares
Novelix Pharmaceuticals Ltd has disclosed a substantial acquisition of shares by its promoter group. Vupparapalli Chandrasekhar Reddy and Vupparapalli Pavani, acting as Persons Acting in Concert (PAC), have acquired 7,75,000 equity shares. This acquisition, totaling 1.29% of the voting rights, was executed through the conversion of warrants issued via preferential allotment on July 9, 2026. Following this transaction, the promoter group's total holding in Novelix Pharmaceuticals has increased, impacting the company's diluted share capital. The filing is made under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011.
Key Highlights
- Promoter group acquired 7,75,000 equity shares in Novelix Pharmaceuticals.
- Acquisition was via conversion of warrants from preferential allotment.
- Total promoter holding percentage increased post-acquisition.
- Transaction falls under SEBI's Takeover Regulations.
- Diluted share capital of the company is impacted.
Price Impact
More from TRIMURTHI
Novelix Pharma: Neha Gattu Allotted 100,000 Shares Post Warrant Conversion
Srinidhi Fine-Chemicals LLP & Narahari Belide Increase Stake in Novelix Pharma
Novelix Pharma: Neha Gattu Acquires 100,000 Shares via Warrant Conversion